NINDS Neuroscience Funding Announcements

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

NINDS Administrative Supplements: Overcoming Barriers to Neurological Therapeutics Development
Release Date: October 30, 2003
Announcement Number: NOT-NS-04-001

Funding Contact: Jill Heemskerk, Ph.D.
Program Area: Office of Translational Research

Brief Description:
The goal of this program is to open critical paths in pre-clinical therapeutics development by funding small, focused projects. Supported studies should be designed to demonstrate the promise of therapies to 1) reduce the barriers to commercial development or 2) justify NIH funding for additional pre-clinical or clinical development. Thus, proposals should demonstrate both a sound rationale for the proposed project and a feasible plan to support further development of the candidate therapy. The proposed intervention(s) should have clearly demonstrated promise as treatments for neurological disease based on data from previous in vitro, animal or clinical testing. Highest funding priority will be given to studies that are specifically designed to support an IND application for clinical testing, and that form part of a well-developed plan for pursuing an IND.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives